Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)

China · Delayed Price · Currency is CNY

37.96

+1.36 (3.72%)

At close: Jun 18, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceutical Manufacturing	801.14M	359.90M	91.29M		10.29M	27.76M
Pharmaceutical Manufacturing Growth	122.60%	294.24%	-		-62.95%	-32.32%
Total	801.14M	359.90M	91.29M		10.29M	27.76M
Total Growth	122.60%	294.24%	-		-62.95%	-32.32%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	801.14M	-	-		-	-
Total	801.14M	-	-		-	-